Gablimet Tablets

Adult dose

This medication is generally recommended to be taken with food or immediately after meals. 1. If a patient has no prior experience with diabetes medication and sufficient blood glucose control is not achievable with monotherapy, the initial dose can be 50/500mg taken once a day, gradually increasing to 50/1000mg taken twice a day, 1 tablet at a time. 2. In combination therapy with Vildagliptin and Metformin.

This medication can cause severe lactic acidosis or hypoglycemia, and caution is required. It should not be used in patients with moderate to severe impairment of kidney function or in patients with cardiovascular diseases such as congestive heart failure or acute myocardial infarction. If undergoing examinations using iodine-based contrast agents, this medication should be discontinued 48 hours prior to the examination and can be resumed only after confirming normal kidney function. It should not be administered to individuals with hypersensitivity to this medication or in patients with type 1 diabetes or diabetic ketoacidosis. Patients with severe infections, severe trauma, or scheduled surgery should temporarily stop this medication and resume only after their condition improves and kidney function is confirmed to be normal. Patients with poor nutritional status or impaired liver function and those who consume excessive alcohol should avoid this medication. Women who are pregnant or breastfeeding should not use this medication. Irregular meals, excessive exercise, and combination with certain medications may increase the risk of hypoglycemia and lactic acidosis, so caution is needed. This medication contains the dye Yellow No. 5, so patients allergic to this substance should use it carefully. During treatment, side effects such as headache, dizziness, nausea, and hypoglycemia may occur, and if symptoms such as abnormal liver function, skin rash, or joint pain develop, you should consult a doctor immediately. Particularly, if acute pancreatitis symptoms occur, treatment should be stopped immediately. This medication is not suitable for patients with type 1 diabetes requiring insulin therapy. Regular monitoring of blood sugar, as well as kidney and liver function tests, is necessary, and vitamin B12 levels should also be checked periodically. In cases of overdose, supportive treatment and possibly dialysis may be required. There may be symptoms like dizziness when driving or operating machinery, so caution is advised, and alcohol consumption should be avoided. This medication is not recommended for children and adolescents under 18 years of age. Elderly patients are at risk of reduced kidney function, so dose adjustments and regular kidney function testing are necessary. If any unusual symptoms occur while taking this medication, consult a healthcare professional immediately.

Serious side effects

Hives, angioedema, hepatitis, skin lesions (including blisters and exfoliative skin lesions), lactic acidosis, hypoglycemia, liver abnormalities (jaundice-related symptoms are not specified but include hepatitis and liver function abnormalities), severe allergic reactions (hives, angioedema, etc.), severe edema (including angioedema)

Mild side effects

• Tremor
• headache
• dizziness
• fatigue
• nausea
• gastroesophageal reflux
• diarrhea
• bloating
• chills
• decreased blood sugar

This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. By storing it this way, the efficacy and safety of the medication can be maintained for a longer period.

Appearance

Bright yellow oval film-coated tablet

Package unit

PTP - 30 tablets/box [10 tablets/PTP X3], PTP - 60 tablets/box [10 tablets/PTP X6]